Lilly(Eli) & Co (NYSE:LLY) currently has a daily average trading volume of 4.17M but it saw 3130534 shares traded in last market. With a market cap of 725.81B USD, the company’s current market price of $765.84 came rising about 2.01 while comparing to the previous closing price of $750.78. In past 52 weeks, the stock remained buoying in the range of price level as high as $972.53 and as low as $677.09.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the HSBC Securities which downgraded the stock as “Reduce” in its note to investors issued on April 28, 2025, recommending a price target of between $1150 and $700 for it. BofA Securities issued its recommendations for the stock as it resumed the price target for the stock is $997.
Over the week, LLY’s stock price is moving 6.46% up while it is -6.77% when we observe its performance for the past one month. Year-to-date it is -0.80% down and over the past year, the stock is showing a downside performance of -6.64%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of 5.54 while estimate for next year EPS is 21.79. In next quarter, company is expected to be making quarterly sales of $15.38B as analysts are expecting the sales for current fiscal year at $59.58B and seeing the company making $71.49B in sales next year. Moreover, analysts are in estimates of $14.35B for current-quarter revenue.
Currently, Lilly(Eli) & Co’s total number of outstanding shares is 948.10M with 0.16% of that held by the insiders while 84.04% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 22.10% and return on equity (ROE) at 77.73%. It has a price to earnings ratio (P/E ratio) of 63.44 while having a 25.82 of forward P/E ratio. Stock’s beta reads 0.39. Stock has a price to book (P/B) ratio of 46.06 while price to sale or P/S ratio amounts to 14.81. Its return on asset (ROA) is 14.49% on average.
